Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Alignment Healthcare, Inc. (NASDAQ: ALHC) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a Medicare Advantage-focused health insurer. Alignment files annual and quarterly reports, along with current reports on Form 8-K, that describe its financial condition, operations and key developments in its Medicare Advantage business.
Recent Form 8-K filings show that Alignment uses these reports to announce quarterly financial results and share information discussed with investors and analysts. For example, the company has filed 8-Ks to furnish press releases on second and third quarter results and to outline discussions of strategy, market position and preliminary CMS Star Ratings. These filings often reference non-GAAP measures such as adjusted gross profit and adjusted EBITDA, which are defined and reconciled to the most comparable GAAP measures in accompanying tables.
Alignment’s SEC filings also provide detail on revenue sources and expenses. Condensed consolidated statements of operations list earned premiums and other revenue, along with medical expenses, selling, general and administrative expenses, and depreciation and amortization. Balance sheet information includes medical expenses payable, long-term debt and stockholders’ equity, giving investors a structured view of the company’s capital and obligations.
Through this page, users can track ongoing 8-K disclosures related to earnings releases, guidance updates, investor presentations and other material events. Filings may also reference CMS Star Ratings, membership expectations and risk factors summarized in the company’s Form 10-K and other periodic reports. Stock Titan enhances access to these documents with AI-powered tools that help explain terminology, highlight key sections and summarize lengthy filings, allowing investors to more quickly understand how ALHC reports its performance, membership trends and risk profile.
BILNEY JODY L reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. director Jody L. Bilney received a grant of 16,039 restricted stock units on March 13, 2026. Each unit represents one share of common stock and will vest on the one-year anniversary of the grant date if she continues serving on the board. Bilney has elected to defer delivery of the shares until separation from service or an earlier change of control of the company. Following this award, she holds 129,267 shares of common stock directly.
Alignment Healthcare, Inc. notice of proposed sale: a Form 144 filed reporting planned sales of Common Stock by Hyong (Ken) Kim under a Rule 10b5-1 trading plan. The filing lists two lots acquired on 03/13/2024 (35,000 shares) and 03/13/2025 (19,355 shares).
The filing also discloses recent dispositions within the prior three months: $352,356.88 for 16,506 shares sold on 01/06/2026 and $237,919.52 for 12,694 shares sold on 12/29/2025. The notice identifies a Rule 10b5-1 plan as the sale mechanism.
Alignment Healthcare, Inc. filed a Form 144 reporting proposed sales of Common Stock by an affiliate. The filing lists 25,000 shares acquired upon vesting of restricted stock units on 03/13/2024 and 13,226 shares acquired upon vesting of restricted stock units on 03/13/2025. The securities are identified as shares held at a brokerage account at E-Trade Finance and were granted under the issuer's 2021 Equity Incentive Plan.
Alignment Healthcare, Inc. (ALHC) director Christopher Joyce filed a Form 144 reporting proposed sales of 32,500 shares and 18,818 shares that were acquired upon RSU vesting on 03/13/2024 and 03/13/2025, respectively. The filing notes prior open-market dispositions under a 10b5-1 Sales Plan, showing sales of 10,611 shares on 01/02/2026 for $212,590.32 and 16,187 shares on 12/29/2025 for $303,388.01.
Alignment Healthcare insider Dawn Maroney reported proposed sales of Common Stock via Form 144. The filing lists shares acquired on 03/13/2024 through RSU vesting (32,500 shares) and on 03/13/2025 through RSU vesting (39,785 shares).
The filing also documents recent 10b5-1 sales attributed to Dawn Maroney, including 30000 shares on 03/16/2026, 29,113 shares on 03/12/2026 (proceeds $507,925.32), and multiple earlier 2026 executions such as 30000 shares on 02/17/2026 and 30000 shares on 01/15/2026. The schedule shows additional disposals in January and December 2025.
Alignment Healthcare, Inc. reports proposed sales of Common Stock by affiliated holders via Form 144, listing multiple planned dispositions executed under a 10b5-1 sales plan and RSU vesting events. The filing lists specific transactions including 12/29/2025 sale of 605,648 shares ($11,351,466.51) and earlier 180,000-share sales on 01/12/2026, 02/10/2026, and 03/10/2026 under the 10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021. It also records RSU vesting acquisitions of 82,500 shares on 03/13/2024 and 91,398 shares on 03/13/2025.
Alignment Healthcare reported Rule 144 sale notices covering transactions by Andreas Wagner and planned dispositions of vested restricted stock units. The filing lists two recent sales: 21,118 shares sold on 03/04/2026 for $393,250.95 and 22,238 shares sold on 02/10/2026 for $455,211.86.
The filing also lists vested restricted stock units acquired on 03/13/2024 (15,000 shares) and 03/13/2025 (8,602 shares) that are described as securities to be sold.
Alignment Healthcare reported a Form 144 notice relating to proposed sales of Common Stock by Robert L. Scavo. The filing lists securities acquired on 03/13/2024 (17,500 shares) and 03/13/2025 (13,226 shares) via RSU vesting, and discloses recent sales of 4,044 shares on 03/12/2026 for $70,554.34 and 69,541 shares on 12/29/2025 for $1,303,384.48.
Alignment Healthcare, Inc. Chief Information Officer Robert L. Scavo reported selling 4,044 shares of common stock in open-market transactions to cover tax withholding obligations tied to vesting restricted stock units. The sales were not discretionary trades. After these transactions, he continues to hold 498,970 shares of Alignment Healthcare common stock directly.
Alignment Healthcare, Inc. president Dawn Christine Maroney reported selling a total of 29,113 shares of common stock on March 12, 2026 in open-market transactions. Footnotes state these shares were sold solely to cover tax withholding obligations tied to vesting restricted stock units and were not discretionary trades. After these sales, she continues to hold 963,702 shares of Alignment Healthcare common stock directly.